Assessment of cytoreductive surgery for diaphragmatic diseases in advanced-stage ovarian cancer

Assessment of cytoreductive surgery for diaphragmatic diseases in advanced-stage ovarian cancer - Assessment of diaphragmatic surgery in ovarian cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034494

Enrollment

150

Registered

2018-12-01

Start date

2018-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Stage IIIB to IV ovarian cancer patients who underwent surgery between 2006 and 2016

Exclusion criteria

Exclusion criteria: Cases without informed consent

Design outcomes

Primary

Measure	Time frame
Survivals in advanced-stage ovarian cancer patients with diaphragmatic diseases	—

Countries

Japan

Contacts

Public ContactSachiko Sawada

Cancer Institute Hospital Department of Clinical Research

med.shinsa@jfcr.or.jp03-3520-0111

Outcome results